Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Sues ApexBio Technology, Alleging Patent Infringement

This story has been updated to address requests for comment from Illumina and ApexBio Technology

NEW YORK – Illumina has sued ApexBio Technology, a Houston-based molecular biology reagents supplier, alleging patent infringement.

In a complaint filed Wednesday in the US District Court for the Southern District of Texas, Illumina alleged that in 2019, ApexBio began selling a next-generation sequencing library preparation kit for Illumina's platform without authorization, infringing Illumina's US Patent No.10,184,122 titled "Transposon End Compositions and Methods for Modifying Nucleic Acids."

Illumina said that in January 2019, ApexBio ordered two Illumina library preparation products. "After purchasing and examining Illumina's … products, ApexBio began making its own product," according to the complaint.

Illumina demanded a jury trial and asked the court for a declaration that ApexBio willfully infringed Illumina's patent, an injunction against the firm, damages, costs, and attorneys fees, among other relief.

The San Diego-based sequencing technology firm was issued the '122 patent nine days before ApexBio allegedly ordered the Illumina library prep products.

Illumina declined to comment. ApexBio did not respond to request for comment. 

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.